Redesign Health
Aron Szanto serves as the Head of Technology at Redesign Health, focusing on transforming healthcare through technological advancements. Concurrently, Aron holds the position of Advisory Partner at Asymmetric and has been the Chief Technology Officer at OccamzRazor, where efforts are directed towards an AI-enabled clinical trial for Parkinson’s Disease. Previously, Aron was the Head of Machine Learning Products at PathAI, overseeing a substantial team to develop AI-driven diagnostics and treatments for diseases. From 2018 to 2022, Aron excelled at Kensho Technologies, managing a division of AI experts and contributing to a successful $44B acquisition. Additionally, Aron founded the Zerobase Foundation, developing a digital contact tracing platform to combat Covid-19, and collaborated with top-tier organizations for innovative machine learning solutions. Aron's earlier roles include associated researcher at Harvard University and key positions at MarketFactory and R.G. Niederhoffer Capital Management, showcasing a robust background in machine learning, product development, and data analysis.
This person is not in any teams
Redesign Health
10 followers
Redesign Health is a company that powers innovation in healthcare by developing technologies, tools, and insights that lower the barriers to change across the industry. Since 2018, exceptional founders have built over two dozen companies at Redesign Health, impacting more than ten million lives across many aspects of the healthcare ecosystem including cancer care, teleaudiology, COVID-19 testing, metabolic health and more. To learn more visit redesignhealth.com.